-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The key to CAR-T cell therapy is the genetic modification of a patient's T cells
Moffitt researchers are working to identify tumor markers that will make CAR-T an effective treatment for patients with solid tumors
The researchers then created CAR-T cells that targeted the OR2H1 protein
These combined data suggest that OR2H1 may be an effective target for CAR-T therapy in solid tumors
"Given that OR2H1 is expressed in a variety of histological subsets of solid tumors, including high-grade serous ovarian, lung, cholangiocarcinoma, prostate, and ovarian cancers of various other histologies, our work demonstrates that this treatment is effective in various
Alexandra L.